nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—AKR1B1—blood plasma—Creutzfeldt-Jakob disease	0.127	0.131	CbGeAlD
Sulindac—MAPK3—blood plasma—Creutzfeldt-Jakob disease	0.0917	0.0948	CbGeAlD
Sulindac—PTGDR2—cerebellum—Creutzfeldt-Jakob disease	0.0666	0.0688	CbGeAlD
Sulindac—PTGDR2—brain—Creutzfeldt-Jakob disease	0.0541	0.0559	CbGeAlD
Sulindac—AKR1B1—lymphoid tissue—Creutzfeldt-Jakob disease	0.0492	0.0509	CbGeAlD
Sulindac—AKR1B1—spinal cord—Creutzfeldt-Jakob disease	0.0446	0.0461	CbGeAlD
Sulindac—PPARD—lymphoid tissue—Creutzfeldt-Jakob disease	0.0387	0.04	CbGeAlD
Sulindac—AKR1B1—central nervous system—Creutzfeldt-Jakob disease	0.0362	0.0374	CbGeAlD
Sulindac—MAPK3—lymphoid tissue—Creutzfeldt-Jakob disease	0.0357	0.0369	CbGeAlD
Sulindac—AKR1B1—cerebellum—Creutzfeldt-Jakob disease	0.0354	0.0366	CbGeAlD
Sulindac—MAPK3—spinal cord—Creutzfeldt-Jakob disease	0.0324	0.0334	CbGeAlD
Sulindac—CYP1A2—blood plasma—Creutzfeldt-Jakob disease	0.0288	0.0297	CbGeAlD
Sulindac—AKR1B1—brain—Creutzfeldt-Jakob disease	0.0288	0.0297	CbGeAlD
Sulindac—PPARD—central nervous system—Creutzfeldt-Jakob disease	0.0285	0.0294	CbGeAlD
Sulindac—PPARD—cerebellum—Creutzfeldt-Jakob disease	0.0278	0.0288	CbGeAlD
Sulindac—MAPK3—central nervous system—Creutzfeldt-Jakob disease	0.0263	0.0271	CbGeAlD
Sulindac—MAPK3—cerebellum—Creutzfeldt-Jakob disease	0.0257	0.0265	CbGeAlD
Sulindac—PTGS1—blood plasma—Creutzfeldt-Jakob disease	0.0249	0.0257	CbGeAlD
Sulindac—PTGS2—blood plasma—Creutzfeldt-Jakob disease	0.0238	0.0246	CbGeAlD
Sulindac—PPARD—brain—Creutzfeldt-Jakob disease	0.0226	0.0234	CbGeAlD
Sulindac—MAPK3—brain—Creutzfeldt-Jakob disease	0.0208	0.0215	CbGeAlD
Sulindac—SLC22A6—brain—Creutzfeldt-Jakob disease	0.0159	0.0165	CbGeAlD
Sulindac—ALB—brain—Creutzfeldt-Jakob disease	0.00994	0.0103	CbGeAlD
Sulindac—PTGS2—lymphoid tissue—Creutzfeldt-Jakob disease	0.00927	0.00958	CbGeAlD
Sulindac—PTGS1—spinal cord—Creutzfeldt-Jakob disease	0.0088	0.00909	CbGeAlD
Sulindac—PTGS2—spinal cord—Creutzfeldt-Jakob disease	0.00841	0.00869	CbGeAlD
Sulindac—CYP1A1—central nervous system—Creutzfeldt-Jakob disease	0.00812	0.00839	CbGeAlD
Sulindac—PTGS1—central nervous system—Creutzfeldt-Jakob disease	0.00714	0.00737	CbGeAlD
Sulindac—PTGS2—central nervous system—Creutzfeldt-Jakob disease	0.00682	0.00705	CbGeAlD
Sulindac—PTGS2—cerebellum—Creutzfeldt-Jakob disease	0.00667	0.00689	CbGeAlD
Sulindac—CYP1A1—brain—Creutzfeldt-Jakob disease	0.00645	0.00666	CbGeAlD
Sulindac—PTGS1—brain—Creutzfeldt-Jakob disease	0.00566	0.00585	CbGeAlD
Sulindac—PTGS2—brain—Creutzfeldt-Jakob disease	0.00541	0.00559	CbGeAlD
Sulindac—AKR1B1—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.00392	0.122	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.00217	0.0673	CbGpPWpGaD
Sulindac—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00197	0.0612	CbGpPWpGaD
Sulindac—MAPK3—Ceramide signaling pathway—CTSD—Creutzfeldt-Jakob disease	0.00175	0.0542	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00175	0.0542	CbGpPWpGaD
Sulindac—MAPK3—NCAM signaling for neurite out-growth—PRNP—Creutzfeldt-Jakob disease	0.00161	0.0499	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.00142	0.0441	CbGpPWpGaD
Sulindac—MAPK3—GMCSF-mediated signaling events—YWHAZ—Creutzfeldt-Jakob disease	0.00136	0.0423	CbGpPWpGaD
Sulindac—MAPK3—Role of Calcineurin-dependent NFAT signaling in lymphocytes—YWHAZ—Creutzfeldt-Jakob disease	0.00101	0.0312	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000966	0.03	CbGpPWpGaD
Sulindac—MAPK3—mTOR signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000857	0.0266	CbGpPWpGaD
Sulindac—CYP1A1—PPARA activates gene expression—NPAS2—Creutzfeldt-Jakob disease	0.000788	0.0245	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000786	0.0244	CbGpPWpGaD
Sulindac—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NPAS2—Creutzfeldt-Jakob disease	0.000772	0.0239	CbGpPWpGaD
Sulindac—PPARD—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000633	0.0196	CbGpPWpGaD
Sulindac—MAPK3—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.000591	0.0183	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.000578	0.0179	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000544	0.0169	CbGpPWpGaD
Sulindac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000532	0.0165	CbGpPWpGaD
Sulindac—MAPK3—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000514	0.016	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000461	0.0143	CbGpPWpGaD
Sulindac—MAPK3—Interferon Signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.000455	0.0141	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000431	0.0134	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000383	0.0119	CbGpPWpGaD
Sulindac—PPARD—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00035	0.0109	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000349	0.0108	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000329	0.0102	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000326	0.0101	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000304	0.00943	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.0003	0.00933	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.00027	0.00837	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000244	0.00758	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000242	0.00751	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000239	0.0074	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000212	0.00657	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000198	0.00616	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000193	0.00599	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000192	0.00596	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—YWHAZ—Creutzfeldt-Jakob disease	0.000172	0.00533	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000171	0.00529	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000168	0.00521	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000157	0.00487	CbGpPWpGaD
Sulindac—ALB—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000155	0.00483	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000139	0.00432	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000135	0.00419	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000134	0.00415	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000109	0.00337	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000106	0.0033	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	9.92e-05	0.00308	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	9.43e-05	0.00293	CbGpPWpGaD
Sulindac—MAPK3—Immune System—YWHAZ—Creutzfeldt-Jakob disease	8.81e-05	0.00273	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—YWHAZ—Creutzfeldt-Jakob disease	8.76e-05	0.00272	CbGpPWpGaD
Sulindac—ALB—Metabolism—NPAS2—Creutzfeldt-Jakob disease	8.59e-05	0.00267	CbGpPWpGaD
Sulindac—MAPK3—Disease—YWHAZ—Creutzfeldt-Jakob disease	8.13e-05	0.00252	CbGpPWpGaD
Sulindac—ALB—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	8.08e-05	0.00251	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	6.01e-05	0.00187	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	5.7e-05	0.00177	CbGpPWpGaD
Sulindac—PTGS2—Disease—YWHAZ—Creutzfeldt-Jakob disease	4.84e-05	0.0015	CbGpPWpGaD
